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Intermittent claudication (IC) is a symptom of peripheral arterial disease where a cramp-like 
leg pain is exhibited during walking, which affects gait and limits walking distance. 
Specifically-designed rocker-soled shoes were purported to mechanically unload the calf 
musculature and increase walking distances until IC pain.  
Research Questions 
Do three-curve rocker-soled shoes increase walking distance and what are the 
biomechanical differences during pain-free walking and IC pain-induced walking, when 
compared with control shoes?  
Methods 
Following NHS ethical approval, 31 individuals with claudication (age 69 ± 10 years, stature 
1.7 ± 0.9 m, mass 83.2 ± 16.2 kg, ankle-brachial pressure index 0.55 ± 0.14) were 
randomised in this cross-over trial. Gait parameters whilst walking with rocker-soled shoes 
were compared with control shoes at three intervals of pain-free walking, at onset of IC pain 
(initial claudication distance) and when IC intensifies and prevents them walking any further 
(absolute claudication distance). Two-way repeated measures ANOVA were performed on 
gait variables.  
Results 
When compared with control shoes, rocker-soled shoes reduced ankle power generation 
(mean 2.1 vs 1.6 W/kg, respectively; p=0.006) and altered sagittal kinematics of the hip, 
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knee and ankle. However, this did not translate to a significant increase in initial (138 m vs 
146 m, respectively) or absolute (373 m vs 406 m, respectively) claudication distances. In response 
to IC pain, similar adaptations in temporal-spatial parameters and the sagittal kinematics 
were observed between the shoe types. 
Significance 
The three-curved rocker shoes, in their current design, do not augment gait sufficiently to 
enhance walking distance, when compared with control shoes, and therefore cannot be 
recommended for the intermittent claudication population.  
Clinical Reg No. (ClinicalTrials.gov): NCT02505503 
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Intermittent claudication (IC) is the most common symptom of peripheral arterial 
disease[1]. Atherosclerosis of the lower limb arteries commonly results in ischaemic pain in 
the calves during physical activity; which is relieved by rest[2–4]. Individuals with IC report a 
reduced quality of life due to an impairment of physical functions and IC pain which 
adversely affect gait, limits walking distances and encourages a sedentary lifestyle which has 
poor cardiovascular and ill-health outcomes[5–12]. Current treatments for IC include 
surgery and/or conservative interventions such as smoking cessation, drug management 
and supervised exercise programmes[5,13,14]. However, these treatments can be costly 
and offer no guarantee of improved walking distance or reduction in the severity of IC 
pain[15]. Adaptations to footwear could improve walking ability and increase walking 
distance until the onset of IC pain (initial claudication distance (ICD)) and when the pain 
intensifies and prevents them walking any further (absolute claudication distance 
(ACD))[16]; however the support from literature is sparse and unclear[13,17–19]. Rocker-
soled shoes have been shown to increase the ICD in individuals with IC when compared with 
standard shoes (+77 m; p<0.01 and +89 m; p<0.01, respectively)[19]. It is hypothesised that 
a rapid plantarflexion in the early stance phase, which is a gait characteristic of in individuals 
with IC[20], could hinder the natural rocker of the foot and increase the demand on lower 
limb musculature. Rocker-soled shoes could facilitate or reinstate the natural rocker of the 
foot, therefore reducing the demands on lower limb musculature and improving ICD and 
ACD. A recent pilot study by Hutchins et al.[13] found that a three-curve rocker-soled shoe 
(Fig.1.) doubled the pain-free walking distance and reduced the intensity of IC pain by 43% 
when compared with stock therapeutic shoes (n=8). Hutchins et al.[13] hypothesised that 
rocker-soled shoes might reduce the metabolic demands and mechanically unload the calf 
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musculature by 25% when compared with un-adapted shoes, thus allowing individuals to 
increase ICD. This evidence of an unloading effect was from unpublished thesis data[21] and 
found in healthy participants (n=12). The applicability of these findings to the IC population 
is questionable due differences in gait between individuals with IC and age-matched healthy 
controls, even when walking without IC pain[20,22–24]. In contrast to Richardson[19] and 
Hutchins et al.[13], our research group  has previously reported no difference in ICD during 
usual pace walking (n=34) between rocker-soled shoe design and standard shoe (164 
± 132 m vs 160 ± 88 m, respectively)[25]. Direct comparison of the rocker shoe literature in 
IC is difficult due to subtle differences in shoe design, walking assessments and variation in 
the description of IC pain given to individuals with IC (e.g. 'bothered by pain'[19] and 'onset 
of pain'[13,25]). Lastly, the effect of rocker-soled shoes on ACD, which is a key indicator of 
walking ability, was not considered by Hutchins et al.[13] or by our group, previously[25]. 
Therefore the aim of this study was to identify the effect of three-curve rocker shoes on 





The study was approved by the NRES Committee for Yorkshire & The Humber - Leeds West 
(Ref: 15/YH/0107), and prospectively registered (ClinicalTrials.gov: NCT02505503). 
Participants were recruited from vascular outpatient clinics of a teaching hospital and 
provided written informed consent to participate. Inclusion criteria were: aged ≥16 years; 
stable symptoms of IC for ≥3 months; resting ankle-brachial pressure index (ABPI) ≤0.9 
and/or imaging evidence of peripheral arterial disease; pain-free walking distance <250 m 
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on 6-minute walk test with walking limited primarily by calf IC (assessed at screening visit). 
Those with critical limb ischemia; absolute contraindications to exercise testing; lower-limb 
amputation; co-morbidities that limit walking before IC pain (e.g. lower-limb osteoarthritis); 
ambulation limited by IC in regions other than the calf; major ankle or foot pathology, and; 
current or previous (within 6 months) use of orthoses, lower-limb braces or customised 
shoes prescribed by a health professional were excluded from the study. Further 
information on the recruitment to the study is presented in the CONSORT flow diagram 
(Fig.1.). 
*** Figure 1 about here *** 
Shoes and Randomisation 
After participant eligibility was confirmed in the screening visit, shoe size was assessed and 
both the rocker-soled and control shoes were ordered from an established shoe 
manufacturer (Chaneco; www.chaneco.co.uk). The rocker-soled shoe was a trainer-type 
shoe with a black leather upper section, laces, and a specially-designed rocker sole (Patent 
no.: GB2458741B) (Fig. 2B). The rocker-soled shoes were adapted from the design used in 
Hutchins et al.[13] but still maintained the same fundamental design of three circular 
curves. The arcs of these curves were formed from radii centred on the sagittal plane 
anterior-posterior position of the ankle, hip and knee during a standing position and 
assuming a vertical line between them all. This design purports to position the ground 
reaction force lines of action closer to lower limb joint centres, and thus joint moments and 
powers might be reduced. This would only be true when the lower limb is in vertical 
position, or at mid-stance. The apex position of the intervention shoe was in line with the 
anterior-posterior position of the anatomical ankle joint. The control shoe had a through-
wedge rocker sole, toe-only curved rocker (Fig.2A) and an apex positioned proximal to the 
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first metatarsal head. As the control shoe shared characteristics of a typical trainer shoe and 
was similar in appearance and weight to the rocker-soled shoe, both researchers and 
participants were blinded.   
*** Figure 2 about here *** 
The order of testing for each participant (i.e., rocker-soled shoes first then control shoes, or 
vice versa) was determined using a computer-generated randomisation sequence (blocked 
randomisation with a block size of 8) created by an otherwise uninvolved statistician. The 
allocations were blinded (i.e. labelled AB and BA) to the statistician and researchers. Once a 
participant had completed the screening visit, participants were assigned to the next 
available randomised allocation.  
 
Walking Gait Assessment 
Participants visited the gait laboratory on two occasions separated by a minimum of 48 
hours. On each visit, participants were allowed to habituate to wearing the allocated pair of 
shoes for 30-45 minutes before commencing the walking gait assessment[26]. Three-
dimensional optical motion analysis was used to analyse the gait of participants whilst 
walking on a level surface, along a 20m figure-of-8 circuit. Eleven Oqus 300 cameras 
(Qualisys, Gothenburg, Sweden) tracked the coordinate data (200Hz) of spherical 
retroreflective markers adhered to the skin or tight fitting clothing overlying landmarks of 
the lower limbs in a six-degrees-of-freedom model. Markers were positioned on both legs 
on the anterior superior iliac spine, posterior superior iliac spine, greater trochanter, medial 
and lateral femoral epicondyle, medial and lateral malleoli, calcaneous, and the superior 
aspect of the foot, plus the 1st and 5th metatarsal heads. Cluster markers (markers on a rigid 
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baseplate) were positioned on the lateral aspect of the thigh and shanks. Following a static 
capture, the medial and lateral femoral epicondyles, medial and lateral malleoli and greater 
trochanter markers were removed prior to the walking trials. Participants were naive to a 
piezoelectric force plate (9281B, Kistler, Switzerland) embedded in the floor in the central 
10m straight portion of the circuit and captured kinetic data. Participants were asked to 




Marker coordinate data and kinetic data from two passes through the 10m capture volume 
(two trials) of pain-free walking, two trials immediately after ICD and the final two trials 
before ACD were processed and analysed. The markers were labelled in Qualisys Track 
Manager software (Qualisys, Gothenburg, Sweden) and exported to Visual 3D motion 
analysis software (C-Motion, Rockville, MD, USA) for processing and analysis. Raw marker 
coordinate data was interpolated and filtered using a zero-lag fourth order low-pass 
Butterworth filter with a cut-off frequency of 6 Hz[24]. Kinetic data was subject to a low 
pass filter with a cut-off frequency of 15 Hz[27]. Kinematic and kinetic data were computed, 
cropped and normalised to 100% gait cycle with 0% indicating initial foot contact[7]. Only 
the limb affected by IC was analysed. Temporal-spatial parameters of interest included 
walking velocity, step length, cadence and contact times. Kinematic and kinetic variables of 
interest at the hip, knee and ankle included joint range of motion, peak joint angles, joint 
angles at toe off, peak sagittal plane joint moments and powers, and moment and power at 
toe off.  
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Statistical Analysis  
IBM SPSS Statistics for Windows, Version 20 (SPSS, IBM Corp., Armonk, NY, USA) software 
was used in two-sided statistical tests at the 5% significance level. A two-way repeated 
measures ANOVA test with post-hoc analysis (Bonferroni pairwise comparisons) was used to 
compare walking distances and the gait variables between the two shoe types and at the 




Thirty-one participants completed the gait analysis in both shoes. The participant group 
comprised of 25 men and 6 women with a mean age 69 ± 10 years, stature 1.7 ± 0.09 m, 
mass 83.2 ± 16.2 kg and ankle-brachial pressure index 0.55 ± 0.14. 
 
Temporal-spatial Parameters 
*** Table 1 here *** 
Temporal-spatial parameters are presented in table 1. A main effect for shoes was not 
observed in any of the temporal-spatial parameters. A main effect for time was observed 
and post-hoc analysis indicated a decreased velocity, step length, and a decrease in double 
limb support as IC pain intensified from pain-free to ICD and ACD. A decrease in cadence 








*** Table 2 here *** 
Sagittal plane kinematics of the pelvis, hip, knee and ankle are presented in table 2. Main 
effects were observed between shoes. When compared with the control shoe, the rocker-
soled shoes increased pelvic transverse plane rotation range of motion and peak 
plantarflexion, but reduced sagittal plane range of motion at the hip, knee and ankle; knee 
flexion at toe-off and peak knee flexion during the swing phase. A main effect for time was 
observed and post-hoc analysis indicated an increased pelvic tilt and a reduced dorsiflexion 
in swing, plantarflexion at toe-off as IC pain intensified from pain-free to ICD and ACD. An 
increased hip angle at toe off, and a reduction in knee range of motion and peak 
plantarflexion were found between ICD-ACD and pain-free-ACD.  
 
Kinetics 
*** Table 3 here *** 
Joint powers of the hip, knee and ankle are presented in table 3. A main effect was observed 
between shoes and indicated a reduced peak ankle power generation in the rocker-soled 
shoes when compared with the control shoes. A main effect for time indicated a decrease in 
hip power generation at toe off and peak knee power generation, however the significance 
level of 5% was met, marginally (p=0.042 and p=0.050). Post-hoc analysis was unable to 







This study aimed to identify the effect of three-curve rocker shoes on walking distance and 
the biomechanics of walking whilst pain-free, at ICD and ACD. Our data suggests that three-
curve rocker shoes reduced plantarflexor power generation and altered kinematics of the 
hip, knee and ankle when compared with the control shoes. Many changes in 
temporal-spatial parameters and sagittal plane kinematics were observed between pain-
free, ICD and ACD whereas few kinetic variables were observed; especially at the ankle. 
Despite the differences between shoes, the key finding of this study was that the three-
curve rocker shoes did not significantly increase ICD or ACD. 
 The three-curve rocker design has previously demonstrated a doubling of ICD in a 
pilot study by Hutchins et al.[13]. Our study found a small but non-significant increase in 
continuous walking ICD (+8 m) and ACD (+33 m) whilst wearing rocker-soled shoes when 
compared with control shoes. In our previous study[25], ICD was measured during self-
paced walking and during a 6-minute walking test. Both walking tests were performed over 
30 m lengths, rather than 10 m lengths used in this study, and also found no differences in 
walking distances whilst wearing the rocker-soled shoes when compared with the control 
shoes. Therefore, this study agrees with previous research regarding this specific rocker 
design and we can confirm that the assessment task did not affect the main finding.   
 The three-curve rocker shoe was purported to mechanically unload the calf 
musculature in healthy individuals and it was hypothesised that this could allow individuals 
with IC to walk further before experiencing pain[13]. In our study, peak ankle power 
generation was reduced in the three curve rocker-soled shoes, which could be indicative of 
more passive placement of the foot into a plantarflexed position at toe off due to a 
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potential reduced mechanical load on the calf musculature and/or a load-sharing co-
activation of other lower limb musculature. Greater peak plantarflexion in the early stages 
of swing was observed and could be due to a continuation of the rocker effect of the shoes. 
Despite greater peak plantarflexion, ankle ROM was reduced in the rocker-soled shoes and 
must be a result of a reduced dorsiflexion as the tibia advances in the latter stages of the 
stance phase and attributable to the rocker placing the foot into a more plantarflexed 
position. 
 The purpose of ankle power generation and plantarflexion is to propel the lower 
limbs into the swing phase, advancement of the lower limb and to ensure adequate foot 
clearance from the floor[28,29]. There is no evidence of compensatory mechanisms for the 
reduced ankle power generation in the joint moments or powers at the knee or hip whilst 
wearing the rocker-soled shoes. Similarly, no differences were detected in the hip angle or 
ankle sagittal plane angle. However, the knee was less flexed at toe-off and in swing phase, 
and the rotation range of motion at the pelvis was greater in the rocker-soled shoes. The 
increased rotation range of motion at the pelvis is a strategy to enhance limb advancement 
and the reduced knee flexion were likely a result of reduced propulsion at toe off and 
attributable to the position of the apex and 'rocking' effect of the rocker-soled shoes. The 
reduced knee flexion in the swing phase could reduce the foot clearance of individuals with 
IC, therefore any rocker-soled shoe should be designed to ensure adequate foot clearance 
to reduce tripping and falls risk, and allow individuals with IC to negotiate obstacles.  
 As IC pain intensified from pain-free walking, ICD and ACD, many changes in 
temporal-spatial parameters and sagittal plane joint kinematics were observed. However, 
kinetic changes were restricted to the hip and knee. Reductions in velocity, step length, 
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cadence, and increase in gait cycle time were also observed. It has been reported previously 
that individuals with IC tend to walk slowly as a result of lower cadence and shorter stride 
length, greater stance time, double stance, and reduced single stance and these are 
exacerbated with the progression of pain[4,7,12,30]. A slower walking speed and higher 
proportion of time spent in contact with the ground is a strategy to enhance balance and 
reduce the likelihood of falling at the expense of walking velocity[4,7,30] and has been 
demonstrated in our study. Our study reflects previous research, where individuals with IC 
wore their own shoes, 'stock' or 'laboratory standard' shoes, and found that kinematic 
adaptations to IC pain were observed at the pelvis and hip, with few at the knee and most 
notable adaptations being observed at the ankle[7,20,24]. Interestingly, ankle joint kinetics 
did not change in response to IC pain, which contradicts the findings of Koutakis et al.[23] 
who found a reduction in ankle power generation during walking with IC pain. In our study, 
there is some evidence of compensatory changes at the hip which could have reduced the 
demands on the ankle. As IC pain increased, hip flexion angle at toe off increased, which is 
reflective of the increase in hip power generation. These changes at the hip likely 
compensated for the reduction in knee power generation, also observed by Koutakis et 
al.[23], and reduced the demand on the calf musculature to propel the lower limb as IC pain 
intensified; hence there were no changes in ankle power generation. This compensatory 
mechanism was observed in both shoe test conditions and therefore, in response to IC pain, 
rocker-soled shoes were unable to alter the kinematic and kinetics of walking gait 






The shape of the rock-soled shoe was the same as Hutchins et al.[13], however the bulk of 
the sole was reduced under the rearfoot to blind the participants and researchers. In 
reducing the bulk, it is likely that the apex of the shoe was moved anteriorly and this 
reduced the rocker effect. Therefore, direct comparisons with the study by Hutchins et 
al.[13] are problematic. The gait analyses were carried out during continuous walking of 
10 m lengths, due to laboratory size, involved many turns and could have affected the 
metabolic load on calf musculature. This study assessed the affected limb only and does not 
address the gait asymmetries which have been reported previously[4,7,12,30].   
 
Conclusions 
There is evidence that the rocker soled shoe altered key gait parameters, however there 
was no clinical benefit to individuals with IC in terms of walking distances when compared 
with the control shoes. Consequently, there is little evidence to support the current design 
of the rocker-soled shoe for individuals with IC. The rocker-soled shoes showed some 
promise as ankle power generation was reduced which could be indicative of a reduction in 
or sharing of the load on calf musculature. Further investigation is required to optimise the 
rocker effect, potentially by moving the apex of the shoe posteriorly, to enhance walking 
distances in individuals with IC. 
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• Ineligible (n=4) 
• 6MWT not primarily limited by calf 
claudication(n=3) 
• Walking limited by claudication in 
regions otherthan calf (n=1) 
• Pain-free 6MWT distance ≥250m 
(n=1) 
• Pain not related to vascular 
pathology (n=1) 
• Resting ABI ≥0.9 (n=1) 
• Withdrew prior to randomisation 
(n=1) 
Randomised (n=37) 
Allocated to receive 
rocker-soled shoes, 
then control  shoes 
(n=19) 
Received rocker-
soled shoes (n=18) 
Received control 
shoes (n=1) 
Allocated to receive 
control shoes, then 
rocker-soled shoes 
(n=18) 
Withdrew from trial 







soled shoes (n=1) 
Received rocker-
soled shoes (n=15) 





































Figure 1. CONSORT flow diagram of the recruitment to the study. 
 




Table 1. Mean (standard deviation) temporal-spatial parameters of individuals with IC wearing control (A) and rocker-soled (B) shoes during the three time 
intervals of pain-free (PF), initial claudication distance (ICD) and absolute claudication distance (ACD). Significance level set at p<0.05 and significant 
changes represented by shaded boxes. A significant 'main effect of shoe' indicates difference between control and rocker-soled shoe and a significant 'main 




Distance (m) 138 (72) 146 (94) 373 (227) 406 (212) 0.393 <0.001 - , <0.001, - 0.607
Velocity (m/s) 1.16 (0.26) 1.17 (0.26) 1.13 (0.27) 1.12 (0.27) 1.07 (0.25) 1.06 (0.25) 0.798 <0.001 0.001,<0.001,<0.001 0.330
Step length (m) 0.63 (0.11) 0.64 (0.11) 0.62 (0.11) 0.62 (0.11) 0.60 (0.10) 0.61 (0.10) 0.977 <0.001 0.022, 0.008,<0.001 0.230
Step candence 
(steps/min) 111.1 (10.0) 110.7 (10.9) 110.3 (10.4) 109.1 (10.8) 108.1 (11.4) 107.2 (10.9) 0.678 <0.001
0.102, 0.001, <0.001 0.120
Gait cycle time (s) 1.09 (0.09) 1.09 (0.11) 1.10 (0.10) 1.11 (0.12) 1.12 (0.13) 1.12 (0.13) 0.973 0.003 0.180, 0.072, 0.025 0.189
Stance time          (% 
gait cycle) 64.1 (2.0) 63.8 (2.0) 64.5 (2.6) 64.0 (2.2) 64.4 (2.8) 64.6 (2.6) 0.290 0.092
0.371, 0.909, 0.209 0.600
Double limb support 
(% gait cycle) 28.2 (4.1) 28.0 (3.8) 29.1 (4.2) 28.6 (3.7) 30.0 (4.4) 29.6 (3.7) 0.153 <0.001
0.004, 0.002,<0.001 0.923
PF ICD ACD
P  value (main 
effect of shoe)
P  value (main 
effect of time)
P  value (shoe and 
time interaction)




Table 2. Mean (standard deviation) sagittal plane kinematics of individuals with IC wearing control (A) and rocker-soled (B) shoes during the three time 
intervals of pain-free (PF), initial claudication distance (ICD) and absolute claudication distance (ACD). Significance level set at p<0.05 and significant 
changes represented by shaded boxes. A significant 'main effect of shoe' indicates difference between control and rocker-soled shoe and a significant 'main 




Anterior pelvic tilt ROM (˚) 3.4 (1.5) 3.5 (1.3) 3.7 (1.4) 3.7 (1.3) 4.1 (1.5) 4.3 (1.8) 0.456 0.001 0.047, 0.050, 0.010 0.723
Pelvic rotation ROM (˚) 5.5 (2.6) 7.5 (3.4) 5.9 (3.3) 8.0 (4.7) 5.7 (3.0) 8.4 ((4.1) <0.001 0.143 0.454, 1.000, 0.047 0.515
Hip at toe off (˚) 7.9 (5.8) 8.0 (5.7) 8.0 (5.5) 7.6 (7.1) 9.4 (5.6) 9.8 (7.3) 0.969 0.002 1.000, 0.010, 0.017 0.715
Hip f lexion in sw ing (˚) 34.6 (6.6) 35.4 (7.5) 35.0 (6.8) 34.3 (8.0) 34.7 (6.3) 35.6 (7.8) 0.733 0.131 0.518, 0.387, 1.000 0.460
Hip range of motion (˚) 37.4 (6.1) 36.8 (5.9) 37.6 (6.6) 34.0 (9.1) 35.8 (6.0) 35.1 (5.4) 0.015 0.112 0.268,1.000, 0.097 0.122
Knee at toe off (˚) -44.2 (5.2) -41.7 (4.2) -44.0 (4.8) -42.7 (4.3) -44.5 (5.2) -41.8 (5.3) 0.003 0.703 1.000, 1.000, 1.000 0.185
Peak knee f lexion in sw ing (˚) -60.2 (4.9) -58.2 (4.9) 60.4 (4.7) -58.4 (5.1) -59.8 (5.1) -57.7 (5.3) 0.002 0.055 1.000, 0.048, 0.526 0.923
Knee range of motion (˚) 62.2 (4.7) 59.9 (5.1) 62.1 (5.8) 59.9 (5.5) 61.0 (5.6) 58.4 (5.9) <0.001 0.009 1.000, 0.022, 0.047 0.503
Ankle at toe off (˚) -4.0 (4.7) -4.5 (4.3) -2.3 (4.6) -3.3 (4.4) -0.8 (4.0) -1.1 (4.5) 0.356 <0.001 0.006, 0.003, <0.001 0.462
Peak plantarf lexion (˚) -9.0 (5.0) -10.9 (4.7) -9.1 (4.2) -10.0 (4.8) -6.9 (4.0) -8.2 (4.6) 0.020 <0.001 0.859,<0.001, 0.004 0.219
Dorsif lexion in sw ing (˚) 3.6 (2.7) 2.7 (2.9) 3.0 (3.0) 2.1 (3.3) 2.4 (3.3) 2.0 (3.3) 0.098 <0.001 0.011, 0.043, 0.002 0.216
Ankle range of motion (˚) 24.6 (3.7) 23.7 (3.5) 25.6 (2.8) 23.9 (3.2) 25.2 (2.9) 24.1 (3.0) <0.001 0.329 0.350, 1.000, 1.000 0.175
P  value (shoe 
and time 
interaction)
PF ICD ACD P  value (main 
effect of shoe)
P  value (main 




Table 3. Mean (standard deviation) joint moment and power values of individuals with IC wearing control (A) and rocker-soled (B) shoes during the three 
time intervals of pain-free (PF), initial claudication distance (ICD) and absolute claudication distance (ACD). Significance level set at p<0.05 and significant 
changes represented by shaded boxes. A significant 'main effect of shoe' indicates difference between control and rocker-soled shoe and a significant 'main 




Hip power at toe off (W/kg) 0.7 (0.3) 0.7 (0.2) 0.8 (0.3) 0.8 (0.3) 0.9 (0.4) 0.9 (0.2) 0.591 0.042 0.089, 0.194, 0.500 0.388
Peak hip power generation (W/kg) 1.0 (0.4) 1.0 (0.3) 1.0 (0.4) 0.9 (0.4) 0.8 (0.5) 0.9 (0.3) 0.895 0.123 0.089, 0.194, 0.412 0.422
Peak hip power absorption (W/kg) -0.5 (0.2) -0.6 (0.5) -0.5 (0.2) 0.5 (0.1) -0.6 (0.2) -0.5 (0.2) 0.933 0.917 0.665. 0.704, 0.382 0.618
Knee power at toe off (W/kg) -0.6 (0.3) -0.6 (0.4) -0.8 (0.6) -0.5 (0.1) -0.6 (0.2) -0.4 (0.3) 0.296 0.591 1.000, 1.000, 0.807 0.755
Peak knee power generation (W/kg) 0.8 (0.6) 0.7 (0.6) 0.7 (0.5) 0.6 (0.4) 0.6 (0.3) 0.5 (0.4) 0.266 0.050 0.135, 1.000, 0.219 0.518
Peak knee power absorption (W/kg) -1.4 (0.5) -2.1 (1.7) -1.6 (0.5) -1.4 (0.5) -1.4 (0.4) -1.2 (0.3) 0.665 0.144 1.000, 0.074, 0.329 0.135
Ankle power at toe off (W/kg) 2.1 (0.5) 1.5 (0.7) 1.7 (0.4) 1.5 (0.4) 1.4 (0.5) 1.4 (0.5) 0.082 0.093 0.680, 0.333, 0.128 0.217
Peak ankle power generation (W/kg) 2.3 (0.8) 1.7 (0.8) 2.2 (0.4) 1.6 (0.3) 1.8 (0.4) 1.6 (0.4) 0.006 0.073 1.000, 0.067, 0.229 0.124
Peak ankle power absorption (W/kg) -1.1 (0.3) -1.0 (0.4) -1.2 (0.5) -1.2 (0.3) -1.3 (0.5) -1.2 (0.4) 0.331 0.084 0.318, 1.000, 0.139 0.634
A B
PF ICD ACD P  value (main 
effect of shoe)
P  value (main 
effect of time)
P  value (shoe 
and time 
interaction)A B A B
 
